News and Trends 25 Jan 2018
Novartis Will Bring US Gene Therapy for Blindness to Europe
…gene editing treatment for a rare form of blindness, outside of the United States. The deal totals $170M (€137M), including an upfront payment of $105M (€85M) and $65M (€52M) in…